Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UMBRALISIB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where UMBRALISIB was used for B-cell lymphoma.

Most Reported Side Effects for UMBRALISIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 47 16.0% 2 5
Nausea 36 12.3% 1 5
Disease progression 30 10.2% 2 3
Fatigue 30 10.2% 1 0
Covid-19 16 5.5% 3 13
Nervous system disorder 15 5.1% 0 0
Death 14 4.8% 14 4
Asthenia 13 4.4% 1 2
Off label use 13 4.4% 1 0
Product dose omission issue 12 4.1% 0 3
Anaemia 11 3.8% 0 0
Decreased appetite 11 3.8% 1 2
Pyrexia 11 3.8% 0 0
Dizziness 10 3.4% 0 3
Drug ineffective 10 3.4% 0 0

Other Indications for UMBRALISIB

Chronic lymphocytic leukaemia (66) Non-hodgkin's lymphoma (50) Follicular lymphoma (48) Product used for unknown indication (42) Diffuse large b-cell lymphoma (20) Marginal zone lymphoma (20) Lymphoma (9)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

UMBRALISIB Full Profile All B-cell lymphoma Drugs UMBRALISIB Demographics UMBRALISIB Timeline